Journal of Antimicrobial Chemotherapy 2003-09-01

Differentiation of genotypic resistance profiles for amprenavir and lopinavir, a valuable aid for choice of therapy in protease inhibitor-experienced HIV-1-infected subjects.

Denise Paulsen, Robert Elston, Wendy Snowden, Margaret Tisdale, Lisa Ross

Index: J. Antimicrob. Chemother. 52(3) , 319-23, (2003)

Full Text: HTML

Abstract

Related Compounds

  • Amprenavir

Related Articles:

A comparison of in vitro ADME properties and pharmacokinetics of azithromycin and selected 15-membered ring macrolides in rodents.

2014-12-01

[Eur. J. Drug Metab. Pharmacokinet. 39(4) , 263-76, (2014)]

Parallel ultra high pressure liquid chromatography-mass spectrometry for the quantification of HIV protease inhibitors using dried spot sample collection format.

2014-08-15

[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 965 , 244-53, (2014)]

HZ08 reverse P-glycoprotein mediated multidrug resistance in vitro and in vivo.

2015-01-01

[PLoS ONE 10(2) , e0116886, (2015)]

Extreme multidrug resistant HIV-1 protease with 20 mutations is resistant to novel protease inhibitors with P1'-pyrrolidinone or P2-tris-tetrahydrofuran.

2013-05-23

[J. Med. Chem. 56(10) , 4017-27, (2013)]

Suppression of pre adipocyte differentiation and promotion of adipocyte death by anti-HIV drugs.

2012-01-01

[In Vivo 26(2) , 287-91, (2012)]

More Articles...